Highbridge Capital Management’s Baird Medical Investment Holdings BDMD Stock Holding History

Highbridge Capital Management’s Portfolio BDMD Stock Details BDMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$230K	Hold	125,000	–	–	0.01%	179
2025 Q4	$170K	Hold	125,000	–	–	0.01%	162
2025 Q3	$265K	Hold	125,000	–	–	0.01%	131
2025 Q2	$458K	Hold	125,000	–	–	0.02%	126
2025 Q1	$651K	Buy	125,000 +12,500	+11%	+$74.9K	0.03%	95
2024 Q4	$855K	Buy	+112,500	New	+$311K	0.03%	129

Other funds holding BDMD

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

National Bank of Canada Montreal, Quebec, Canada $140B AUM 46.34% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.66% 1-Year Est. Return

Highbridge Capital Management's BDMD Position: Q1 2026 in Review

Highbridge Capital Management held its Baird Medical Investment Holdings (BDMD) position steady in Q1 2026 at 125,000 shares worth $230K. The position accounts for 0.01% of the portfolio, ranked #179.

Highbridge Capital Management first reported a position in BDMD in Q4 2024 and has held it in 6 quarters since. The position peaked at $855K in Q4 2024. 8 funds tracked by Wall St. Rank hold BDMD as of Q1 2026.

Highbridge Capital Management held 125,000 shares of Baird Medical Investment Holdings worth $230K as of Q1 2026.
Highbridge Capital Management left its Baird Medical Investment Holdings share count unchanged in Q1 2026.
Baird Medical Investment Holdings made up 0.01% of Highbridge Capital Management's portfolio in Q1 2026, its #179 holding.
Highbridge Capital Management first reported a position in Baird Medical Investment Holdings in Q4 2024 and has held it in 6 quarters since.
Highbridge Capital Management's Baird Medical Investment Holdings position peaked at $855K in Q4 2024.
8 funds tracked by Wall St. Rank held Baird Medical Investment Holdings as of Q1 2026.

Based on Highbridge Capital Management's 13F filing for Q1 2026, filed 15 May 2026.